Jack Ady Cancer Centre in Lethbridge to host prostate cancer radiation trial
About two dozen patients will initially take part in a study testing whether radiation treatments for prostate cancer can be reduced. Organizers say a second group of patients will be added later.
Why it matters
The trial could reduce travel and treatment burdens for southern Alberta cancer patients who would otherwise need to seek such studies in larger cities.
The Jack Ady Cancer Centre in Lethbridge has been chosen to host a new clinical trial examining whether the number of radiation treatments needed by some prostate cancer patients can be significantly reduced. The trial was announced Wednesday.
Ryan Kelly of the Alberta Cancer Foundation said trials like this are typically conducted in larger centres such as Calgary or Edmonton, making Lethbridge's involvement notable. He said bringing the study to a smaller centre supports the foundation's goal of offering clinical trials closer to where patients live.
Kelly noted that reducing the number of required treatments would cut down on travel and time commitments for patients and their families during cancer treatment. The trial will begin with about two dozen participants, with plans to add another cohort of patients in the future.
Compiled by the Alberta Daily Desk — an AI-written summary of reporting from the credited sources below, produced and reviewed under our editorial policy.